Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Mizuki Nishino, MD, MPH


No Ratings Available - Why Not? Make an Appointment

Mizuki Nishino, MD, MPH


  • Physician
  • Vice Chair of Faculty Development, Department of Imaging
  • Professor of Radiology, Harvard Medical School


Clinical Interests

  • Immunotherapy
  • Lung cancer
  • Oncologic imaging
  • Precision oncology
  • Thoracic imaging

Contact Information

  • Office Phone Number617-632-2595
  • Fax617-582-8574

Board Certification:

  • Diagnostic Radiology, 2008


  • Beth Israel Deaconess Medical Center, Thoracic Imaging


  • Beth Israel Deaconess Medical Center, Diagnostic Radiology

Medical School:

  • Kyoto University Faculty of Medicine, Japan

Recent Awards:

  • R01 award from the National Cancer Institute (PI: Nishino, 1R01CA203636, 2017-2021) “Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment” 2017
  • Magna Cum Laude- Dynamic Chest Radiography Using Flat Panel Detector System: Technique and Application. RSNA 2016, Chicago, IL, Nov 2016
  • Cum Laude- Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care. RSNA 2016, Chicago, IL, Nov 2016
  • Merck Investigator Studies Program (PI: Nishino, 2016-2018). “Quantitative imaging analysis during pembrolizumab therapy in advanced melanoma patients: providing an objective marker for survival and therapeutic decisions” 2016
  • Editors' Recognition Award for Distinction in Reviewing, Journal of Thoracic Imaging. 2014, 2015
  • Diagnosis Please Award for Cases 205-216 published in 2014. Announcement in: Radiology. 2015; 277: 314-7. 2014
  • Diagnosis Please Award for Cases 181-192 published in 2012. Announcement in: Radiology. 2013; 269: 627-31. 2012
  • Dana-Farber Cancer Institute Fellowship for the Eleanor and Miles Shore 50th Anniversary Fellowship Program. (PI: Nishino, 2012) “Quantification of Apoptotic Activity in Non-small-cell Lung Cancer treated with Targeted Therapy: A pilot study.” 2012
  • K 23 Award from the National Cancer Institute (5K23CA157631, PI: Nishino, 2011-2016) “CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation” 2011
  • RSNA Research Scholar Grant, RSNA R&E Foundation (PI: Nishino, 2009-2011) "Chronological Analysis of Tumor Size, Volume and CT attenuation coefficient in Women with Adenocarcinoma of the Lung Treated with Erlotinib" 2009


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions